ViGenCell Inc (308080)

KOSDAQ
Currency in KRW
2,570
-50(-1.91%)
Closed
308080 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2,5552,650
52 wk Range
2,3055,360
Key Statistics
Edit
Bid/Ask
2,570.00 / 2,575.00
Prev. Close
2,620
Open
2,615
Day's Range
2,555-2,650
52 wk Range
2,305-5,360
Volume
38.39K
Average Volume (3m)
183.07K
1-Year Change
-51.03%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
308080 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple
Show more

ViGenCell Inc Company Profile

ViGenCell Inc. specializes in immune cell therapy. It develops ViTier, a T-cell therapy platform that uses antigen-specific killer T cells to target and remove cancer cells; ViRanger, a T-cell gene therapy platform that uses innate killer T cells to target and eliminate abnormal cells; and ViMedier, an immunosuppressive cell therapy platform that uses the differentiation and expansion of cord blood derived myeloid suppressor cells for universal use. The company was founded in 1995 and is based in Seoul, South Korea.

Compare 308080 to Peers and Sector

Metrics to compare
308080
Peers
Sector
Relationship
P/E Ratio
−3.3x−5.9x−0.6x
PEG Ratio
−0.26−0.090.00
Price/Book
0.8x2.7x2.6x
Price / LTM Sales
909.4x11.5x3.1x
Upside (Analyst Target)
-0.0%51.5%
Fair Value Upside
Unlock9.8%8.4%Unlock

Earnings

Latest Release
Mar 15, 2023
EPS / Forecast
-237.26 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the ViGenCell (308080) Stock Price Today?

The ViGenCell stock price today is 2,570.00

What Stock Exchange Does ViGenCell Trade On?

ViGenCell is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for ViGenCell?

The stock symbol for ViGenCell is "308080."

What Is the ViGenCell Market Cap?

As of today, ViGenCell market cap is 50.47B.

What is ViGenCell Earnings Per Share?

The ViGenCell EPS is -799.80.

From a Technical Analysis Perspective, Is 308080 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.